AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Tuesday reported a loss of $8.3 million in its third quarter.

The Austin, Texas-based company said it had a loss of $1.04 per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

The biopharmaceutical company posted revenue of $7,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LUMO at https://www.zacks.com/ap/LUMO

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News